PBLA

Panbela Therapeutics News

Company Name Stock Ticker Symbol Market Type
Panbela Therapeutics Inc PBLA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0591 -16.46% 0.2999 11:49:53
Open Price Low Price High Price Close Price Prev Close
0.2501 0.2501 0.3012 0.359
more quote information »

Recent News

Date Time Source Heading
9/30/202208:37GLOBEPanbela Announces Pricing of Approximately $6 Million Public..
9/30/202206:05EDGARNotice of Effectiveness (effect)
9/29/202209:00GLOBEPanbela Receives Approvals to Open Trial Sites in Spain,..
9/06/202206:02EDGARSecurities Registration Statement (s-1/a)
8/25/202208:02EDGARCurrent Report Filing (8-k)
8/19/202217:25EDGARSecurities Registration Statement (s-1)
8/15/202216:20EDGARQuarterly Report (10-q)
8/15/202216:10GLOBEPanbela Provides Business Update and Reports Q2 2022..
8/11/202209:00GLOBEPanbela Announces First Patient Enrolled in its Aspire Trial..
8/04/202209:00GLOBEPanbela Expands Aspire Trial to Australia, Studying SBP-101..
8/01/202216:00GLOBEPanbela Schedules Conference Call on, August 15, 2022, to..
7/20/202206:03EDGARCurrent Report Filing (8-k)
7/20/202206:02EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
6/28/202208:00GLOBEPanbela Announces Publication of Preclinical Data Titled:..
6/27/202208:44EDGARInitial Statement of Beneficial Ownership (3)
6/23/202206:01EDGARPost-effective Amendment to an S-8 Filing (s-8 Pos)
6/23/202206:01EDGARSecurities Registration: Employee Benefit Plan (s-8)
6/22/202217:21EDGARPost-effective Amendment to Registration Statement (pos Am)
6/22/202217:20EDGARPost-effective Amendment to Registration Statement (pos Am)
6/16/202208:16EDGARNotification That a Class of Securities of Successor Issuer..
6/16/202208:00GLOBEPanbela Therapeutics, Inc. Closes Acquisition of Cancer..
5/14/202210:15TRMNMaxim Group Initiates a Buy Rating on Panbela Therapeutics..
5/12/202216:14EDGARQuarterly Report (10-q)
5/12/202216:11EDGARCurrent Report Filing (8-k)
5/12/202216:05GLOBEPanbela Provides Business Update and Reports Q1 2022..
5/04/202217:30BWPANBELA THERAPEUTICS INVESTOR ALERT - Kuznicki Law PLLC..
4/27/202208:30GLOBEPanbela to Host Virtual R&D Day
4/26/202208:30GLOBEPanbela Schedules Conference Call on May 12, 2022, to Report..
4/12/202208:30GLOBEPanbela Announces Poster Presentation at American..
3/28/202208:47EDGARPost-effective Amendment to Registration Statement (pos Am)
3/28/202208:46EDGARSecurities Registration: Employee Benefit Plan (s-8)
3/26/202207:35TRMNMaxim Group Keeps Their Buy Rating on Panbela Therapeutics..
3/24/202217:02SEEKPanbela Therapeutics GAAP EPS of -$0.26
3/24/202216:14EDGARAnnual Report (10-k)
3/24/202216:08EDGARCurrent Report Filing (8-k)
3/24/202216:05GLOBEPanbela Provides Business Update and Reports Q4 and FY 2021..
3/23/202208:30GLOBEPanbela to Participate in a Panel Discussion: “Pancreatic..
3/10/202208:30GLOBEPanbela to Participate in the 34th Annual Roth Conference
3/08/202208:30GLOBEPanbela Schedules Conference Call on March 24, 2022, to..
3/07/202208:30GLOBEAcceptance of SBP-101 Abstract for Poster Presentation at..
2/22/202208:48SEEKPanbela Therapeutics agrees to acquire Cancer Prevention..
2/22/202208:04EDGARCurrent Report Filing (8-k)
2/22/202208:04EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
2/22/202208:00GLOBEPanbela Therapeutics, Inc. to Acquire Cancer Prevention..
1/26/202214:14SEEKPanbela begins phase 2 study of SBP-101 combo to treat..
1/26/202209:00GLOBEPanbela Initiates a Randomized, Double-Blind,..
1/24/202209:45SEEKPanbela posts interim data from early-stage trial for..
1/24/202209:00GLOBEPanbela Presents Clinical Data on Phase 1b Clinical Trial of..
12/14/202109:00GLOBEPanbela Announces Positive Preclinical Data Strongly..
11/18/202109:00GLOBEPanbela Announces Acceptance of Abstract for Poster..


Your Recent History
NASDAQ
PBLA
Panbela Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now